Annual report pursuant to Section 13 and 15(d)

Income Tax Expense (Tables)

v3.7.0.1
Income Tax Expense (Tables)
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Schedule of Income Tax Benefit (Provision)

    The Company’s income tax benefit/(provision) is as follows:

 

    Years Ended December 31  
    2016     2015  
Current   $ 895,000     $ 3,228,852  
Deferred     (1,646,000     835,596  
Change in Valuation Allowance     751,000       (3,795,104 )
Net   $ -     $ 269,344  

Components of Deferred Tax Assets and Related Valuation Allowances

    The principle components of the deferred tax assets and related valuation allowances as of December 31, 2016 and 2015 are as follows:

 

    Years Ended December 31  
    2016     2015  
Reserves and other   $ 865,000     $ 2,506,000  
Net operating loss carry-forwards     21,618,000       20,728,000  
Valuation Allowance     (22,483,000     (23,234,000 )
Net   $ -     $ -  

Reconciliation of Income Taxes Using Statutory U.S. Income Tax Rate and Benefits from Income Taxes

    The reconciliation of income taxes using the statutory U.S. income tax rate and the benefit from income taxes for the years ended December 31, 2016 and 2015 are as follows:

 

    Years Ended December 31  
    2016     2015  
Statutory U.S. Federal Income Tax Rate     (35.0 )%     (35.0 )%
New Jersey State income taxes, net of U.S. Federal tax effect     (6.0 )%     (6.0 )%
Benefit from Sale of New Jersey NOL     0.0 %     (2.9 )%
Change in Valuation Allowance     41.0 %     41.0 %
Net     - %     (2.9 )%